Creative Medical Technology Holdings, Inc. (CELZ) Earning

NASDAQ Currency in USD Disclaimer

$2.08

north_east $0.08 (4%)
Day's range
$2
Day's range
$2.17

Creative Medical Technology Holdings, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.84 -$0.84 -$0.84
Q2 2024 1 -$0.75 -$0.75 -$0.75
Q3 2024 1 -$0.63 -$0.63 -$0.63
Q1 2025 1 -$0.64 -$0.64 -$0.64
Q2 2025 1 -$0.54 -$0.54 -$0.54
Q3 2025 1 -$0.54 -$0.54 -$0.54
Q4 2025 1 -$0.54 -$0.54 -$0.54

Creative Medical Technology Holdings, Inc. Earnings Date And Information

Creative Medical Technology Holdings, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.75 earnings per share for the quarter, topping analysts' consensus estimates of $-0.85 by $0.1. The company had revenue of 0 for the quarter and had revenue of 9,000 for the year. Creative Medical Technology Holdings, Inc. has generated $-4 earnings per share over the last year ($-3.76 diluted earnings per share) and currently has a price-to-earnings ratio of -0.54. Creative Medical Technology Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.

Creative Medical Technology Holdings, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/08/2024 Q3 2024 -$0.85 -$0.75 0.1 $0 $0
08/09/2024 Q2 2024 -$0.84 -$1.11 -0.27 $8,000 $8,000
05/10/2024 Q1 2024 -$1.15 -$0.73 0.42 $0
04/29/2024 Q4 2023 -$1.21 $3,000
11/14/2023 Q3 2023 -$0.86 -$1.02 -0.16 $6,000
08/11/2023 Q2 2023 -$0.83 -$0.78 0.05 $15,000 $0
05/12/2023 Q1 2023 -$1.00 -$0.70 0.3 $0
05/01/2023 Q4 2022 -$4.37 $18,600
11/10/2022 Q3 2022 -$0.13 -$0.70 -0.57 $110,000 $55,000
08/12/2022 Q2 2022 -$0.15 -$2.25 -2.1 $100,000 $10,000
05/13/2022 Q1 2022 -$0.14 -$1.79 -1.65 $15,000
03/30/2022 Q4 2021 -$0.23 -$11.13 -10.9 $67,754
11/15/2021 Q3 2021 -$7.52 $10,000
08/16/2021 Q2 2021 -$12.52 $10,000
05/17/2021 Q1 2021 $122.20 $0
03/17/2021 Q4 2020 -$251.26 $17,500
11/13/2020 Q3 2020 $5.80 $77,000
08/14/2020 Q2 2020 -$54.46 $27,900
05/15/2020 Q1 2020 $450.00 $42,100
04/06/2020 Q4 2019 -$1,154.54 $-4,400
 

Creative Medical Technology Holdings, Inc. Earnings: FAQ's

When is Creative Medical Technology Holdings, Inc.'s earnings date?

Creative Medical Technology Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.

Did Creative Medical Technology Holdings, Inc. beat their earnings estimates last quarter?

In the previous quarter, Creative Medical Technology Holdings, Inc. (:CELZ) reported $-0.75 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.85 by $0.1.

How can I listen to Creative Medical Technology Holdings, Inc.'s earnings conference call?

The conference call for Creative Medical Technology Holdings, Inc.'s latest earnings report can be listened to online.

How can I read Creative Medical Technology Holdings, Inc.'s conference call transcript?

The conference call transcript for Creative Medical Technology Holdings, Inc.'s latest earnings report can be read online.

How much revenue does Creative Medical Technology Holdings, Inc. generate each year?

Creative Medical Technology Holdings, Inc. (:CELZ) has a recorded annual revenue of $9,000.

How much profit does Creative Medical Technology Holdings, Inc. generate each year?

Creative Medical Technology Holdings, Inc. (:CELZ) has a recorded net income of $9,000. Creative Medical Technology Holdings, Inc. has generated $-3.76 earnings per share over the last four quarters.

What is Creative Medical Technology Holdings, Inc.'s price-to-earnings ratio?

Creative Medical Technology Holdings, Inc. (:CELZ) has a price-to-earnings ratio of -0.54 and price/earnings-to-growth ratio is -0.08.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED